Customer Center
Login | Register
 
 

Clinical

Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
 
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
 
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
 
Learn More

Luminex® Blog

ARIES® GBS Assay Outperforms Culture Testing in a Multisite Study

Results show excellent clinical performance, sensitivity, specificity, reproducibility, and ease of use

A new publication released in the Journal of Clinical Microbiology reports results of a multisite analysis of the ARIES® GBS Assay. Lead author Diana R. Hernandez from Geisinger, senior author Arundhati Rao from Baylor Scott and White Health, and collaborators issued their findings in the paper entitled “Multicenter Diagnostic Accuracy Evaluation of the Luminex® ARIES® Real-Time PCR Assay for Group B Streptococcus detection in Lim-Enriched samples.”

Continue Reading >

xMAP® Technology Overview

 
Luminex xMAP® Technology Overview

 

xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter


RT @WebMD: UPDATE: There are now 163 people across 10 states who have gotten sick after reportedly eating a salad from McDonald's, accordin…
h J R
Targeted testing? We do that. Syndromic testing? We do that too! https://t.co/7vnf7gjShI https://t.co/QvVClvfbfs
h J R
Universal screening guidelines for women at end of pregnancy has helped reduce #GBS infections by 27% in just a few… https://t.co/GsNLbpcfyG
h J R

Latest News

June 13
Luminex Initiates Clinical Trials for VERIGENE® II Gastrointestinal Assay

May 18
Luminex Corporation to Present at Upcoming Healthcare Investor Conferences

May 18
Luminex Corporation Declares Second Quarter Cash Dividend

May 7
Luminex Corporation Reports First Quarter 2018 Financial Results

April 16
Luminex Corporation First Quarter Earnings Release Scheduled for May 7, 2018

Events

ECI
2-5 September
Amsterdam, Netherlands

Microbe UK
21-23 September
Sheffield, UK

World Vaccine Congress
29-31 October
Lisbon, Portugal